Amoxycillin & Potassium Clavulanate Tablets

PRODUCT NAME : Axocilin-cv 625 Amoxycillin & Potassium Clavulanate TabletsΒ 

Dosage Form: Tablet

Axocilin-CV 625 is a combination antibiotic formulation containing Amoxycillin and Potassium Clavulanate, available in tablet dosage form. It is part of the pharmaceutical product portfolio of Biomorph Lifesciences and is intended for use under the guidance of a qualified healthcare professional.Amoxycillin belongs to the penicillin group of antibiotics and works by interfering with bacterial cell-wall formation. Potassium Clavulanate helps inhibit certain beta-lactamase enzymes produced by bacteria, which can reduce the effectiveness of some antibiotics. Together, the combination may be prescribed for selected bacterial infections when considered appropriate by a healthcare professional.

Axocilin-CV 625 may be used for certain infections involving the respiratory tract, urinary tract, skin and soft tissues, and other susceptible bacterial infections. The appropriate dose and treatment duration depend on the patient’s condition and should be determined by a healthcare professional.Patients should inform their doctor about any previous allergy to penicillin, cephalosporins, or other antibiotics before using this medicine.For pharmaceutical businesses, Biomorph Lifesciences also provides PCD pharma franchise opportunities. Contact the team for product availability, pricing, and business partnership details.

Category: Brand:

Description

MORE DETAILS ABOUT PRODUCT

Axocilin-cv 625

  • Uses: May be prescribed for selected bacterial infections affecting the respiratory tract, urinary tract, skin and soft tissues, and other susceptible sites.
  • How It Works: Amoxycillin interferes with bacterial cell-wall formation, while Potassium Clavulanate helps inhibit certain beta-lactamase enzymes that can reduce amoxycillin’s antibacterial activity.
  • Dosage: Should be taken only as directed by a qualified healthcare professional.Β 
  • Precautions: Inform your healthcare professional about previous allergies to penicillins, cephalosporins, or other antibiotics before use.
  • Product Availability: Axocilin-CV 625 is part of the pharmaceutical portfolio of Biomorph Lifesciences and may be available for eligible PCD pharma franchise and business partners. Contact the Biomorph Lifesciences team for current availability, pricing, and partnership details.

Indications

Key Benefits of Amoxycillin & Potassium Clavulanate Tablets

  • Combination Antibiotic: Contains Amoxycillin and Potassium Clavulanate for combined antibacterial activity.
  • Broad Antibacterial Coverage: Helps manage infections caused by susceptible bacteria when prescribed by a healthcare professional.
  • Enhanced Amoxycillin Activity: Potassium Clavulanate helps inhibit certain beta-lactamase enzymes that may reduce the effectiveness of amoxycillin.
  • Multiple Therapeutic Uses: May be prescribed for selected bacterial infections affecting the respiratory tract, urinary tract, skin, and soft tissues.
  • Convenient Tablet Form: Provides an easy-to-administer oral dosage form when antibiotic therapy is appropriate.
  • Established Combination: The amoxycillin and clavulanate combination is commonly used when beta-lactamase-producing bacteria may be involved.
  • Pharmaceutical Product Portfolio: Axocilin-CV 625 is offered by Biomorph Lifesciences and can be included in suitable PCD pharma franchise portfolios.